Medicago’s vaccine candidates is proudly developed in Canada.
A plant-based vaccine candidate is developed from virus-like particles (VLPs). VLPs mimic the native structure of viruses, allowing them to be recognized as such by the immune system.
After extraction, these VLPs are purified to obtain the final material needed for vaccine manufacturing. Safety and sterility tests are performed to meet regulatory standards.
An adjuvant designed to enhance the immune response may be combined with the vaccine candidate.
The role of the vaccine is to help the immune system learns to recognize the targeted viruses so the body can better fight.
